26.08.2020
The hospital provides assistance and treated patients with acute respiratory disease COVID-19, caused by coronavirus SARS COV-2 light and moderate severity. For the purpose of timely and differential diagnostics on the COVID-19 institution purchased and commissioned the apparatus of the IFA LABLINE-90.
Now it is possible to give an IFA test (IGM, IgG) on the COVID-19 in our laboratory. The capacity of the IFA LABLINE-90 device, in the presence of required reagents 180 analyzes per day. The results of analyzes can be obtained within 1 day after blood collection. In some cases, if necessary, this term may be reduced to 2-3 hours.
Diagnostic methods can be divided into two main groups:
Immuno-enzyme analysis (IgM, IgG) detects a complex of antigen-antibodies that are produced when the body is affected by the virus. The method of IFA testing determines the immunoglobulins of two types - M and G. Immunoglobulins m indicate the existence of an active immune response, that is, that a person is currently ill for coronavirus infection. Immunoglobulins G, in turn, mean that a person is already overflowed or infected with a virus, so it has developed antibodies to this disease.
An IFA test detects an immune response to a virus - the level of antibodies.
If IFA testing will detect an antibody in a patient, such a patient will provide a sample for PCR diagnostics.
The use of IFA tests to detect the COVID-19 antibodies regulated by the Order of MOH of 20.05.2020 No. 1227 "On Approval of Amendments to Medical Aid Standards" Coronavirus Disease "(COVID-19).
(с) 2024